{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:33:10Z","timestamp":1793298790260,"version":"4.5.0"},"reference-count":191,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.mayocp.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T07:41:13Z","timestamp":1556696473000},"page":"892-905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"title":["Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6760-3859","authenticated-orcid":false,"given":"Nathan P.","family":"Staff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"s1","key":"10.1016\/j.mayocp.2019.01.001_bib1","first-page":"S21","article-title":"Replacing dopamine neurons in Parkinson's disease: how did it happen?","volume":"7","author":"Bj\u00f6rklund","year":"2017","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"7724","key":"10.1016\/j.mayocp.2019.01.001_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/d41586-018-06756-9","article-title":"Clear up this stem-cell mess","volume":"561","author":"Sipp","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A\u00a0perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.mayocp.2019.01.001_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","volume":"15","author":"Bourin","year":"2013","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2014.01.013","article-title":"MSC-based product characterization for clinical trials: an FDA perspective","volume":"14","author":"Mendicino","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib6","doi-asserted-by":"crossref","first-page":"e62662","DOI":"10.1371\/journal.pone.0062662","article-title":"Distant mesenchymal progenitors contribute to skin wound healing and produce collagen: evidence from a murine fetal microchimerism model","volume":"8","author":"Seppanen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mayocp.2019.01.001_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-2-8","article-title":"Mesenchymal stem cells avoid allogeneic rejection","volume":"2","author":"Ryan","year":"2005","journal-title":"J\u00a0Inflamm (Lond)"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.5966\/sctm.2016-0071","article-title":"Impact of the secretome of human mesenchymal stem cells on brain structure and animal behavior in a rat model of Parkinson's disease","volume":"6","author":"Teixeira","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.mayocp.2019.01.001_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainres.2011.10.038","article-title":"Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor","volume":"1431","author":"Whone","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.mayocp.2019.01.001_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2001-1326-3-21","article-title":"Safety of repeated transplantations of neurotrophic factors-secreting human mesenchymal stromal stem cells","volume":"3","author":"Gothelf","year":"2014","journal-title":"Clin Transl Med"},{"issue":"5175","key":"10.1016\/j.mayocp.2019.01.001_bib11","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1126\/science.8066451","article-title":"Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF","volume":"265","author":"Mitsumoto","year":"1994","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/neu.2006.0004","article-title":"Rescue of rat anterior horn neurons after spinal cord injury by retrograde transfection of adenovirus vector carrying brain-derived neurotrophic factor gene","volume":"24","author":"Nakajima","year":"2007","journal-title":"J\u00a0Neurotrauma"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/jnr.20668","article-title":"Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice","volume":"82","author":"Narai","year":"2005","journal-title":"J\u00a0Neurosci Res"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nn1360","article-title":"Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS","volume":"8","author":"Storkebaum","year":"2005","journal-title":"Nat Neurosci"},{"issue":"6","key":"10.1016\/j.mayocp.2019.01.001_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3727\/096368910X540630","article-title":"Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism","volume":"20","author":"Park","year":"2011","journal-title":"Cell Transplant"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1471-4159.2008.05589.x","article-title":"Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease","volume":"107","author":"Park","year":"2008","journal-title":"J\u00a0Neurochem"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib17","doi-asserted-by":"crossref","first-page":"e19808","DOI":"10.1371\/journal.pone.0019808","article-title":"Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection","volume":"6","author":"Stemberger","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.expneurol.2006.05.027","article-title":"GDNF gene delivery via the p75NTR receptor rescues injured motor neurons","volume":"202","author":"Barati","year":"2006","journal-title":"Exp Neurol"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1440-1789.2005.00609.x","article-title":"Peripheral nerve avulsion injuries as experimental models for adult motoneuron degeneration","volume":"25","author":"Watabe","year":"2005","journal-title":"Neuropathology"},{"issue":"9","key":"10.1016\/j.mayocp.2019.01.001_bib20","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/leu.2015.89","article-title":"Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells","volume":"29","author":"Te Boome","year":"2015","journal-title":"Leukemia"},{"issue":"10051","key":"10.1016\/j.mayocp.2019.01.001_bib21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Pan\u00e9s","year":"2016","journal-title":"Lancet"},{"issue":"6301","key":"10.1016\/j.mayocp.2019.01.001_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.mayocp.2019.01.001_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fnins.2016.00193","article-title":"The enemy within: innate surveillance-mediated cell death, the common mechanism of neurodegenerative disease","volume":"10","author":"Richards","year":"2016","journal-title":"Front Neurosci"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4252\/wjsc.v6.i5.526","article-title":"Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy","volume":"6","author":"Glenn","year":"2014","journal-title":"World J Stem Cells"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib25","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s11481-013-9489-x","article-title":"Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis","volume":"8","author":"Zhao","year":"2013","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/stem.2575","article-title":"Concise Review: MSC-derived exosomes for cell-free therapy","volume":"35","author":"Phinney","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.mayocp.2019.01.001_bib27","doi-asserted-by":"crossref","first-page":"36120","DOI":"10.1038\/srep36120","article-title":"Comparative proteomic analysis of extracellular vesicles isolated from porcine adipose tissue-derived mesenchymal stem\/stromal cells","volume":"6","author":"Eirin","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.gene.2014.08.041","article-title":"MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells","volume":"551","author":"Eirin","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.mayocp.2019.01.001_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuroscience.2016.01.061","article-title":"Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth","volume":"320","author":"Lopez-Verrilli","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.mayocp.2019.01.001_bib30","doi-asserted-by":"crossref","first-page":"24805","DOI":"10.1038\/srep24805","article-title":"Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes","volume":"6","author":"Nakano","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib31","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s12035-016-9851-0","article-title":"Exosomes derived from mesenchymal stromal cells promote axonal growth of cortical neurons","volume":"54","author":"Zhang","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"9","key":"10.1016\/j.mayocp.2019.01.001_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.5966\/sctm.2015-0010","article-title":"Improving the post-stroke therapeutic potency of mesenchymal multipotent stromal cells by cocultivation with cortical neurons: the role of crosstalk between cells","volume":"4","author":"Babenko","year":"2015","journal-title":"Stem Cells Transl Med"},{"issue":"7613","key":"10.1016\/j.mayocp.2019.01.001_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature18928","article-title":"Transfer of mitochondria from astrocytes to neurons after stroke","volume":"535","author":"Hayakawa","year":"2016","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.2736","article-title":"Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury","volume":"18","author":"Islam","year":"2012","journal-title":"Nat Med"},{"issue":"pt 6","key":"10.1016\/j.mayocp.2019.01.001_bib35","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/brain\/awr063","article-title":"Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke","volume":"134","author":"Honmou","year":"2011","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.mayocp.2019.01.001_bib36","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A\u00a0long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"issue":"7","key":"10.1016\/j.mayocp.2019.01.001_bib37","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1161\/STROKEAHA.116.012995","article-title":"Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1\/2a study","volume":"47","author":"Steinberg","year":"2016","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","article-title":"Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study","volume":"11","author":"Connick","year":"2012","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.mayocp.2019.01.001_bib39","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"Karussis","year":"2010","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.mayocp.2019.01.001_bib40","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.mayocp.2018.04.007","article-title":"Amyotrophic lateral sclerosis: an update for 2018","volume":"93","author":"Oskarsson","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.1471-4159.2002.00830.x","article-title":"Co-administration of IGF-I and glycosaminoglycans greatly delays motor neurone disease and affects IGF-I expression in the wobbler mouse: a long-term study","volume":"81","author":"Gorio","year":"2002","journal-title":"J\u00a0Neurochem"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2019.01.001_bib42","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/S0022-510X(98)00208-1","article-title":"LIF (AM424), a promising growth factor for the treatment of ALS","volume":"160","author":"Kurek","year":"1998","journal-title":"J\u00a0Neurol Sci"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.expneurol.2006.08.028","article-title":"Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS","volume":"203","author":"Li","year":"2007","journal-title":"Exp Neurol"},{"issue":"7-8","key":"10.1016\/j.mayocp.2019.01.001_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2119\/2006-00045.Mennini","article-title":"Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in\u00a0vitro and in\u00a0vivo","volume":"12","author":"Mennini","year":"2006","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2004.06.004","article-title":"Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration","volume":"17","author":"Van Den Bosch","year":"2004","journal-title":"Neurobiol Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2019.01.001_bib46","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.52.7.1427","article-title":"A\u00a0controlled trial of recombinant methionyl human BDNF in ALS","volume":"52","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.410390215","article-title":"A\u00a0placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis","volume":"39","author":"Miller","year":"1996","journal-title":"Ann Neurol"},{"issue":"22","key":"10.1016\/j.mayocp.2019.01.001_bib48","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/01.wnl.0000335970.78664.36","article-title":"Subcutaneous IGF-1 is not beneficial in 2-year ALS trial","volume":"71","author":"Sorenson","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2006.12.015","article-title":"Lost in translation: treatment trials in the SOD1 mouse and in human ALS","volume":"26","author":"Benatar","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2019.01.001_bib50","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1179\/016164105X39860","article-title":"Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis","volume":"27","author":"Nagano","year":"2005","journal-title":"Neurol Res"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14660820050515197","article-title":"A\u00a0phase I\/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis","volume":"1","author":"Ochs","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"7","key":"10.1016\/j.mayocp.2019.01.001_bib52","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1517\/13543784.2014.912275","article-title":"Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery","volume":"23","author":"Van Damme","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.mayocp.2019.01.001_bib54","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archneur.1990.00530110068019","article-title":"IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis","volume":"47","author":"Engelhardt","year":"1990","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archneur.1993.00540010026013","article-title":"Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis","volume":"50","author":"Engelhardt","year":"1993","journal-title":"Arch Neurol"},{"issue":"40","key":"10.1016\/j.mayocp.2019.01.001_bib56","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0807419105","article-title":"CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS","volume":"105","author":"Beers","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib57","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.bbi.2010.12.008","article-title":"Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice","volume":"25","author":"Beers","year":"2011","journal-title":"Brain Behav Immun"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.tins.2004.03.002","article-title":"Gene therapy for ALS delivers","volume":"27","author":"Boill\u00e9e","year":"2004","journal-title":"Trends Neurosci"},{"issue":"5778","key":"10.1016\/j.mayocp.2019.01.001_bib59","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Boill\u00e9e","year":"2006","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.mayocp.2019.01.001_bib60","doi-asserted-by":"crossref","first-page":"e25545","DOI":"10.1371\/journal.pone.0025545","article-title":"Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells","volume":"6","author":"Nardo","year":"2011","journal-title":"PLoS One"},{"issue":"pt 5","key":"10.1016\/j.mayocp.2019.01.001_bib61","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/brain\/awr074","article-title":"Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis","volume":"134","author":"Beers","year":"2011","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.mayocp.2019.01.001_bib62","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/archneur.65.10.1358","article-title":"A\u00a0potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis","volume":"65","author":"Ragheb","year":"2008","journal-title":"Arch Neurol"},{"issue":"1-2","key":"10.1016\/j.mayocp.2019.01.001_bib63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneuroim.2008.09.017","article-title":"Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)","volume":"206","author":"Zhang","year":"2009","journal-title":"J\u00a0Neuroimmunol"},{"issue":"1-2","key":"10.1016\/j.mayocp.2019.01.001_bib64","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneuroim.2009.07.011","article-title":"Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression","volume":"215","author":"Saleh","year":"2009","journal-title":"J\u00a0Neuroimmunol"},{"issue":"1-2","key":"10.1016\/j.mayocp.2019.01.001_bib65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jneuroim.2004.10.009","article-title":"Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS)","volume":"159","author":"Zhang","year":"2005","journal-title":"J\u00a0Neuroimmunol"},{"issue":"1-2","key":"10.1016\/j.mayocp.2019.01.001_bib66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2009.02.012","article-title":"Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process","volume":"210","author":"Mantovani","year":"2009","journal-title":"J\u00a0Neuroimmunol"},{"issue":"7","key":"10.1016\/j.mayocp.2019.01.001_bib67","doi-asserted-by":"crossref","first-page":"e0182002","DOI":"10.1371\/journal.pone.0182002","article-title":"Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis","volume":"12","author":"Gustafson","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.mayocp.2019.01.001_bib68","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/jamaneurol.2017.2255","article-title":"Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression","volume":"74","author":"Murdock","year":"2017","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.mayocp.2019.01.001_bib69","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1172\/JCI62636","article-title":"Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS","volume":"122","author":"Butovsky","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib70","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10048-014-0420-2","article-title":"miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients","volume":"15","author":"De Felice","year":"2014","journal-title":"Neurogenetics"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gene.2012.07.058","article-title":"A\u00a0miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis","volume":"508","author":"De Felice","year":"2012","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ana.24304","article-title":"Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice","volume":"77","author":"Butovsky","year":"2015","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib73","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.nbd.2004.10.010","article-title":"Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat","volume":"18","author":"Jin","year":"2005","journal-title":"Neurobiol Dis"},{"issue":"12","key":"10.1016\/j.mayocp.2019.01.001_bib74","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/01.wnr.0000227993.07799.a2","article-title":"Magnetic targeting of bone marrow stromal cells into spinal cord: through cerebrospinal fluid","volume":"17","author":"Nishida","year":"2006","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib75","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.expneurol.2004.01.021","article-title":"Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation","volume":"187","author":"Ohta","year":"2004","journal-title":"Exp Neurol"},{"issue":"18","key":"10.1016\/j.mayocp.2019.01.001_bib76","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/01.brs.0000138273.02820.0a","article-title":"Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue","volume":"29","author":"Satake","year":"2004","journal-title":"Spine (Phila Pa 1976)"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib77","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/trf.12938","article-title":"A\u00a0safety study on intrathecal delivery of autologous mesenchymal stromal cells in rabbits directly supporting Phase I human trials","volume":"55","author":"Chen","year":"2015","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.mayocp.2019.01.001_bib78","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jcyt.2014.02.003","article-title":"Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis","volume":"16","author":"Boido","year":"2014","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib79","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yexcr.2015.12.009","article-title":"Exosome derived from murine adipose-derived stromal cells: neuroprotective effect on in\u00a0vitro model of amyotrophic lateral sclerosis","volume":"340","author":"Bonafede","year":"2016","journal-title":"Exp Cell Res"},{"issue":"9","key":"10.1016\/j.mayocp.2019.01.001_bib80","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/jnr.22038","article-title":"Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis","volume":"87","author":"Boucherie","year":"2009","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.mayocp.2019.01.001_bib81","doi-asserted-by":"crossref","first-page":"16953","DOI":"10.1038\/srep16953","article-title":"Adipose-derived stem cell conditioned media extends survival time of a mouse model of amyotrophic lateral sclerosis","volume":"5","author":"Fontanilla","year":"2015","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.mayocp.2019.01.001_bib82","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/stem.1812","article-title":"Intrathecal delivery of mesenchymal stromal cells protects the structure of altered perineuronal nets in SOD1 rats and amends the course of ALS","volume":"32","author":"Forostyak","year":"2014","journal-title":"Stem Cells"},{"issue":"9","key":"10.1016\/j.mayocp.2019.01.001_bib83","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3109\/14653249.2011.592521","article-title":"Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis","volume":"13","author":"Forostyak","year":"2011","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib84","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/acn3.375","article-title":"Additive amelioration of ALS by co-targeting independent pathogenic mechanisms","volume":"4","author":"Frakes","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib85","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neulet.2009.10.074","article-title":"Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice","volume":"468","author":"Kim","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mayocp.2019.01.001_bib86","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuroscience.2013.05.034","article-title":"Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model","volume":"248","author":"Marconi","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.mayocp.2019.01.001_bib87","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2119\/molmed.2011.00498","article-title":"Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis","volume":"18","author":"Uccelli","year":"2012","journal-title":"Mol Med"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib88","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nbd.2008.05.016","article-title":"Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis","volume":"31","author":"Vercelli","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib89","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/14653240701376413","article-title":"Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice","volume":"9","author":"Zhao","year":"2007","journal-title":"Cytotherapy"},{"issue":"21","key":"10.1016\/j.mayocp.2019.01.001_bib90","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.0000000000003359","article-title":"Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS","volume":"87","author":"Staff","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib91","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/14653249.2011.613929","article-title":"Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study","volume":"14","author":"Mazzini","year":"2012","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.mayocp.2019.01.001_bib92","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5966\/sctm.2014-0212","article-title":"Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis","volume":"4","author":"Oh","year":"2015","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib93","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamaneurol.2015.4321","article-title":"Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1\/2 and 2a clinical trials","volume":"73","author":"Petrou","year":"2016","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib94","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mus.24143","article-title":"Rare combination of myasthenia and motor neuronopathy, responsive to Msc-Ntf stem cell therapy","volume":"49","author":"Petrou","year":"2014","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib95","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ana.25302","article-title":"Repeated intrathecal mesenchymal stem cells for amyotrophic lateral sclerosis","volume":"84","author":"Oh","year":"2018","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.mayocp.2019.01.001_bib96","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4065\/70.11.1093","article-title":"Dementia: diagnosis and evaluation","volume":"70","author":"Fleming","year":"1995","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.mayocp.2019.01.001_bib97","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrneurol.2012.135","article-title":"The paradox of syndromic diversity in Alzheimer disease","volume":"8","author":"Warren","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"issue":"pt 5","key":"10.1016\/j.mayocp.2019.01.001_bib99","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/brain\/awv050","article-title":"Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum","volume":"138","author":"Murray","year":"2015","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib101","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J\u00a0Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib102","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib103","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"pt 2","key":"10.1016\/j.mayocp.2019.01.001_bib104","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/brain\/awv338","article-title":"Alzheimer's Disease Neuroimaging Initiative. Cascading network failure across the Alzheimer's disease spectrum","volume":"139","author":"Jones","year":"2016","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(00)81109-5","article-title":"Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles","volume":"24","author":"Mesulam","year":"1999","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib106","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbadis.2009.10.006","article-title":"Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology","volume":"1802","author":"Moreira","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib107","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer's disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib108","doi-asserted-by":"crossref","first-page":"a006346","DOI":"10.1101\/cshperspect.a006346","article-title":"Inflammation in Alzheimer disease\u2014a brief review of the basic science and clinical literature","volume":"2","author":"Wyss-Coray","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib109","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10571-016-0386-8","article-title":"Autophagy and Alzheimer's Disease","volume":"37","author":"Li","year":"2017","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.mayocp.2019.01.001_bib110","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib111","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/nan.12319","article-title":"Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP\/PS1 Alzheimer mice","volume":"43","author":"Naaldijk","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib112","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2174\/15672050113109990027","article-title":"Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-\u03b2 deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease","volume":"10","author":"Bae","year":"2013","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib113","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/scrt227","article-title":"Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an A\u03b2PP\/PS1 transgenic mouse model","volume":"4","author":"Yang","year":"2013","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib114","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neurobiolaging.2010.03.024","article-title":"Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation","volume":"33","author":"Lee","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"6","key":"10.1016\/j.mayocp.2019.01.001_bib115","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2174\/156720510792231739","article-title":"Bone marrow-derived mesenchymal stem cells attenuate amyloid \u03b2-induced memory impairment and apoptosis by inhibiting neuronal cell death","volume":"7","author":"Lee","year":"2010","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"10.1016\/j.mayocp.2019.01.001_bib116","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3727\/096368914X679237","article-title":"Mesenchymal stem cells increase hippocampal neurogenesis and neuronal differentiation by enhancing the wnt signaling pathway in an Alzheimer's disease model","volume":"24","author":"Oh","year":"2015","journal-title":"Cell Transplant"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib117","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13287-017-0567-5","article-title":"Alzheimer's disease, dementia, and stem cell therapy","volume":"8","author":"Duncan","year":"2017","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"10.1016\/j.mayocp.2019.01.001_bib118","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"issue":"pt 12","key":"10.1016\/j.mayocp.2019.01.001_bib119","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1093\/brain\/awv274","article-title":"Clinical features and autonomic testing predict survival in multiple system atrophy","volume":"138","author":"Coon","year":"2015","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mds.20678","article-title":"Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG)","volume":"21","author":"Geser","year":"2006","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.mayocp.2019.01.001_bib121","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1474-4422(15)00058-7","article-title":"Natural history of multiple system atrophy in the USA: a prospective cohort study","volume":"14","author":"Low","year":"2015","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib122","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0002-9440(10)65226-1","article-title":"Widespread alterations of \u03b1-synuclein in multiple system atrophy","volume":"155","author":"Dickson","year":"1999","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.mayocp.2019.01.001_bib123","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1212\/WNL.59.6.944","article-title":"Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy","volume":"59","author":"Benarroch","year":"2002","journal-title":"Neurology"},{"issue":"pt 10","key":"10.1016\/j.mayocp.2019.01.001_bib124","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/brain\/awl109","article-title":"Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy","volume":"129","author":"Benarroch","year":"2006","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib125","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1440-1789.2006.00713.x","article-title":"Cellular pathology in multiple system atrophy","volume":"26","author":"Wakabayashi","year":"2006","journal-title":"Neuropathology"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib126","doi-asserted-by":"crossref","first-page":"e1884","DOI":"10.1371\/journal.pone.0001884","article-title":"DJ-1 modulates \u03b1-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70","volume":"3","author":"Batelli","year":"2008","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.mayocp.2019.01.001_bib127","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01418-5","article-title":"Aggregates from mutant and wild-type alpha\u03b1-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of \u03b2-sheet and amyloid-like filaments","volume":"440","author":"El-Agnaf","year":"1998","journal-title":"FEBS Lett"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/WNR.0b013e3283509842","article-title":"Neuronal to oligodendroglial \u03b1-synuclein redistribution in a double transgenic model of multiple system atrophy","volume":"23","author":"Rockenstein","year":"2012","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib129","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/156720507783018343","article-title":"Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?","volume":"4","author":"Windisch","year":"2007","journal-title":"Curr Alzheimer Res"},{"issue":"18","key":"10.1016\/j.mayocp.2019.01.001_bib130","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1523\/JNEUROSCI.0567-10.2010","article-title":"Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors","volume":"30","author":"Ubhi","year":"2010","journal-title":"J\u00a0Neurosci"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jnen\/63.1.43","article-title":"Microglial activation parallels system degeneration in multiple system atrophy","volume":"63","author":"Ishizawa","year":"2004","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"15","key":"10.1016\/j.mayocp.2019.01.001_bib132","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mds.21671","article-title":"Microglial activation mediates neurodegeneration related to oligodendroglial \u03b1-synucleinopathy: implications for multiple system atrophy","volume":"22","author":"Stefanova","year":"2007","journal-title":"Mov Disord"},{"issue":"pt 8","key":"10.1016\/j.mayocp.2019.01.001_bib133","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/brain\/awv114","article-title":"Expanding the spectrum of neuronal pathology in multiple system atrophy","volume":"138","author":"Cykowski","year":"2015","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.mayocp.2019.01.001_bib134","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.neurobiolaging.2009.12.017","article-title":"Blood-brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy","volume":"32","author":"Song","year":"2011","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.410410114","article-title":"Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor","volume":"41","author":"Winkler","year":"1997","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib136","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.clpt.6100386","article-title":"Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy","volume":"83","author":"Lee","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib137","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.23612","article-title":"A\u00a0randomized trial of mesenchymal stem cells in multiple system atrophy","volume":"72","author":"Lee","year":"2012","journal-title":"Ann Neurol"},{"issue":"14","key":"10.1016\/j.mayocp.2019.01.001_bib138","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","article-title":"Alzheimer's disease and Parkinson's disease","volume":"348","author":"Nussbaum","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mayocp.2019.01.001_bib139","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/jnnp-2012-303135","article-title":"Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology","volume":"84","author":"Asahina","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mayocp.2019.01.001_bib141","first-page":"595","article-title":"The clinical features of Parkinson's disease in 100 histologically proven cases","volume":"60","author":"Hughes","year":"1993","journal-title":"Adv Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib142","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ana.20160","article-title":"Idiopathic hyposmia as a preclinical sign of Parkinson's disease","volume":"56","author":"Ponsen","year":"2004","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib143","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archneur.1996.00550020087019","article-title":"The occurrence of depression in Parkinson's disease: a community-based study","volume":"53","author":"Tandberg","year":"1996","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib144","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-012-1040-2","article-title":"Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss","volume":"124","author":"Annerino","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.24921","article-title":"Lewy pathology and neurodegeneration in premotor Parkinson's disease","volume":"27","author":"Del Tredici","year":"2012","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.mayocp.2019.01.001_bib146","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib147","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 Years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib148","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archneur.1993.00540020018011","article-title":"A\u00a0clinicopathologic study of 100 cases of Parkinson's disease","volume":"50","author":"Hughes","year":"1993","journal-title":"Arch Neurol"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2019.01.001_bib149","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.3949\/ccjm.74.Suppl_1.S91","article-title":"Cardiac denervation in patients with Parkinson disease","volume":"74","author":"Goldstein","year":"2007","journal-title":"Cleve Clin J Med"},{"issue":"5674","key":"10.1016\/j.mayocp.2019.01.001_bib150","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1126\/science.1098966","article-title":"Parkinson's\u2014divergent causes, convergent mechanisms","volume":"304","author":"Greenamyre","year":"2004","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib151","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib152","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/ijms17020151","article-title":"Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of Parkinson's disease\u2014lessons from transgenic mice","volume":"17","author":"Machado","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.mayocp.2019.01.001_bib153","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrn1199","article-title":"The role of \u03b1-synuclein in Parkinson's disease: insights from animal models","volume":"4","author":"Maries","year":"2003","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"10.1016\/j.mayocp.2019.01.001_bib154","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.neuint.2008.02.003","article-title":"Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease","volume":"52","author":"Bouchez","year":"2008","journal-title":"Neurochem Int"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib155","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/jnr.23879","article-title":"Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease","volume":"95","author":"Chen","year":"2017","journal-title":"J\u00a0Neurosci Res"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib156","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/14653240802021330","article-title":"Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease","volume":"10","author":"Levy","year":"2008","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib157","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3940(01)02384-9","article-title":"Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"316","author":"Li","year":"2001","journal-title":"Neurosci Lett"},{"issue":"72","key":"10.1016\/j.mayocp.2019.01.001_bib158","first-page":"133","article-title":"Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease","author":"Offen","year":"2007","journal-title":"J\u00a0Neural Transm Suppl"},{"issue":"8","key":"10.1016\/j.mayocp.2019.01.001_bib159","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/scd.2008.0411","article-title":"Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease","volume":"18","author":"Sadan","year":"2009","journal-title":"Stem Cells Dev"},{"issue":"8","key":"10.1016\/j.mayocp.2019.01.001_bib160","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.cellbi.2009.05.002","article-title":"Clinical grade mesenchymal stem cells transdifferentiated under xenofree conditions alleviates motor deficiencies in a rat model of Parkinson's disease","volume":"33","author":"Shetty","year":"2009","journal-title":"Cell Biol Int"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib161","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.parkreldis.2006.07.013","article-title":"Therapeutic effects of differentiated bone marrow stromal cell transplantation on rat models of Parkinson's disease","volume":"13","author":"Ye","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib162","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/term.504","article-title":"Transplantation of porcine umbilical cord matrix mesenchymal stem cells in a mouse model of Parkinson's disease","volume":"7","author":"Kang","year":"2013","journal-title":"J\u00a0Tissue Eng Regen Med"},{"issue":"1-2","key":"10.1016\/j.mayocp.2019.01.001_bib163","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2012.03.004","article-title":"Neuroprotective effects of human umbilical cord mesenchymal stromal cells in an immunocompetent animal model of Parkinson's disease","volume":"246","author":"Mathieu","year":"2012","journal-title":"J\u00a0Neuroimmunol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib164","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.expneurol.2007.10.011","article-title":"Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease","volume":"210","author":"McCoy","year":"2008","journal-title":"Exp Neurol"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib165","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/rme.15.17","article-title":"Adipose-derived human mesenchymal stem cells induce long-term neurogenic and anti-inflammatory effects and improve cognitive but not motor performance in a rat model of Parkinson's disease","volume":"10","author":"Schwerk","year":"2015","journal-title":"Regen Med"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib166","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jcyt.2014.09.005","article-title":"Human adipose-derived mesenchymal stromal cells increase endogenous neurogenesis in the rat subventricular zone acutely after 6-hydroxydopamine lesioning","volume":"17","author":"Schwerk","year":"2015","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib167","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cbin.10029","article-title":"Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson's disease rodent model","volume":"37","author":"Shetty","year":"2013","journal-title":"Cell Biol Int"},{"issue":"3","key":"10.1016\/j.mayocp.2019.01.001_bib168","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1634\/stemcells.2005-0330","article-title":"Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease","volume":"24","author":"Weiss","year":"2006","journal-title":"Stem Cells"},{"issue":"11","key":"10.1016\/j.mayocp.2019.01.001_bib169","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.bbmt.2010.06.004","article-title":"Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats","volume":"16","author":"Xiong","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.mayocp.2019.01.001_bib170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2009.11.041","article-title":"Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease","volume":"1311","author":"Cova","year":"2010","journal-title":"Brain Res"},{"issue":"10","key":"10.1016\/j.mayocp.2019.01.001_bib171","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.7150\/ijms.8182","article-title":"Opposite effects of bone marrow-derived cells transplantation in MPTP-rat model of Parkinson's disease: a comparison study of mononuclear and mesenchymal stem cells","volume":"11","author":"Capitelli","year":"2014","journal-title":"Int J Med Sci"},{"issue":"10","key":"10.1016\/j.mayocp.2019.01.001_bib172","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.neurobiolaging.2015.06.022","article-title":"Therapeutic potentials of human adipose-derived stem cells on the mouse model of Parkinson's disease","volume":"36","author":"Choi","year":"2015","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib173","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/glia.20731","article-title":"Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action","volume":"57","author":"Kim","year":"2009","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib174","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00330-014-3549-3","article-title":"Improved dopamine transporter binding activity after bone marrow mesenchymal stem cell transplantation in a rat model of Parkinson's disease: small animal positron emission tomography study with F-18 FP-CIT","volume":"25","author":"Park","year":"2015","journal-title":"Eur Radiol"},{"issue":"8","key":"10.1016\/j.mayocp.2019.01.001_bib175","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3727\/096368912X640556","article-title":"Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model","volume":"21","author":"Park","year":"2012","journal-title":"Cell Transplant"},{"key":"10.1016\/j.mayocp.2019.01.001_bib176","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2202-11-52","article-title":"Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1\u03b1","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Neurosci"},{"issue":"9","key":"10.1016\/j.mayocp.2019.01.001_bib177","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.5966\/sctm.2015-0023","article-title":"Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson's disease, focusing on cell distribution and neuroprotective and\u00a0behavioral effects","volume":"4","author":"Cerri","year":"2015","journal-title":"Stem Cells Transl Med"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2019.01.001_bib178","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.3727\/096368914X684970","article-title":"Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease","volume":"23","author":"Danielyan","year":"2014","journal-title":"Cell Transplant"},{"issue":"8","key":"10.1016\/j.mayocp.2019.01.001_bib179","first-page":"561","article-title":"Dopaminergic induction of umbilical cord mesenchymal stem cells by conditioned medium of choroid plexus epithelial cells reduces apomorphine-induced rotation in parkinsonian rats","volume":"19","author":"Aliaghaei","year":"2016","journal-title":"Arch Iran Med"},{"issue":"12","key":"10.1016\/j.mayocp.2019.01.001_bib180","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/jnr.22435","article-title":"Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease","volume":"88","author":"Glavaski-Joksimovic","year":"2010","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.mayocp.2019.01.001_bib181","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuroscience.2015.07.014","article-title":"GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease","volume":"303","author":"Hoban","year":"2015","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.mayocp.2019.01.001_bib182","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainresprot.2005.03.002","article-title":"Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease","volume":"15","author":"Lu","year":"2005","journal-title":"Brain Res Brain Res Protoc"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib183","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3892\/mmr.2014.2878","article-title":"Effects of engineered conserved dopamine neurotrophic factor-expressing bone marrow stromal cells on dopaminergic neurons following 6-OHDA administrations","volume":"11","author":"Mei","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.mayocp.2019.01.001_bib184","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2010.08.040","article-title":"Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the parkinsonian rat brain","volume":"1359","author":"Moloney","year":"2010","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib185","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/gt.2010.152","article-title":"VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease","volume":"18","author":"Xiong","year":"2011","journal-title":"Gene Ther"},{"issue":"8","key":"10.1016\/j.mayocp.2019.01.001_bib186","doi-asserted-by":"crossref","first-page":"e105118","DOI":"10.1371\/journal.pone.0105118","article-title":"The effect of lentivirus-mediated PSPN genetic engineering bone marrow mesenchymal stem cells on Parkinson's disease rat model","volume":"9","author":"Yin","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mayocp.2019.01.001_bib187","doi-asserted-by":"crossref","first-page":"e64000","DOI":"10.1371\/journal.pone.0064000","article-title":"Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in\u00a0vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model","volume":"8","author":"Yan","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib188","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jcyt.2013.01.007","article-title":"Recovery of behavioral symptoms in hemi-parkinsonian rhesus monkeys through combined gene and stem cell therapy","volume":"15","author":"Zhou","year":"2013","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.mayocp.2019.01.001_bib189","first-page":"1491","article-title":"Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease","volume":"187","author":"Soler","year":"2012","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.01.001_bib190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","article-title":"Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease","volume":"155","author":"Venkataramana","year":"2010","journal-title":"Transl Res"},{"key":"10.1016\/j.mayocp.2019.01.001_bib191","doi-asserted-by":"crossref","first-page":"931902","DOI":"10.1155\/2012\/931902","article-title":"Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: a pilot clinical study","volume":"2012","author":"Venkataramana","year":"2012","journal-title":"Stem Cells Int"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619300047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619300047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:31:00Z","timestamp":1758418260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619300047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":191,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0025619619300047"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.01.001","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}